Literature DB >> 20320677

Methaemoglobinaemia due to Sulphanilamide Therapy.

E H Bensley, J B Ross.   

Abstract

Entities:  

Year:  1937        PMID: 20320677      PMCID: PMC1562283     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  The relative value of clinical tests for blood.

Authors:  T F Bloem
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

  1 in total
  4 in total

1.  A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL.

Authors:  A F Hartmann; A M Perley; H L Barnett
Journal:  J Clin Invest       Date:  1938-11       Impact factor: 14.808

2.  THE CONTROL OF METHEMOGLOBINEMIA WITH METHYLENE BLUE.

Authors:  W B Wendel
Journal:  J Clin Invest       Date:  1939-03       Impact factor: 14.808

3.  THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.

Authors:  J S Harris; H O Michel
Journal:  J Clin Invest       Date:  1939-09       Impact factor: 14.808

4.  METHAEMOGLOBINAEMIA AND SULPHAEMOGLOBINAEMIA DUE TO SULPHANILAMIDE.

Authors:  E H Bensley; B Wilén
Journal:  Can Med Assoc J       Date:  1939-07       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.